Evidence map›Paper›PMID 35683521›Full record

ReviewJournal of clinical medicine2022

The Management of Hypertensive Emergencies-Is There a "Magical" Prescription for All?

Ana-Maria Balahura, Ștefan-Ionuț Moroi, Alexandru Scafa-Udrişte, Emma Weiss, Cristina Japie, Daniela Bartoş, Elisabeta Bădilă

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Efficacy of nitroglycerinWorld journal of cardiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Aortic dissection: A challenge for the emergency medicine? A case report].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ana-Maria BalahuraInternal Medicine Department, Bucharest Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Ștefan-Ionuț MoroiDepartment of Cardiology, Emergency Institute for Cardiovascular Diseases "Prof. Dr. C.C. Iliescu", 022328 Bucharest, Romania.
Alexandru Scafa-UdrişteCardiology Department, Bucharest Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Emma WeissInternal Medicine Department, Bucharest Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Cristina JapieInternal Medicine Department, Bucharest Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Daniela BartoşInternal Medicine Department, Bucharest Clinical Emergency Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Elisabeta BădilăDepartment of Cardiology, Colentina Hospital, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.ORCID 0000-0003-2683-3054
Carol Davila University of Medicine and Pharmacy · ROInstitutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu" · RO

Funding

the EEA Grants 2014-2021 33/2021
6 · The paper itself

Abstract

Hypertensive emergencies (HE) represent high cardiovascular risk situations defined by a severe increase in blood pressure (BP) associated with acute, hypertension mediated organ damage (A-HMOD) to the heart, brain, retina, kidneys, and large arteries. Blood pressure values alone do not accurately predict the presence of HE; therefore, the search for A-HMOD should be the first step in the management of acute severe hypertension. A rapid therapeutic intervention is mandatory in order to limit and promote regression of end-organ damage, minimize the risk of complications, and improve patient outcomes. Drug therapy for HE, target BP, and the speed of BP decrease are all dictated by the type of A-HMOD, specific drug pharmacokinetics, adverse drug effects, and comorbidities. Therefore, a tailored approach is warranted. However, there is currently a lack of solid evidence for the appropriate treatment strategies for most HE. This article reviews current pharmacological strategies while providing a stepwise, evidence based approach for the management of HE.

Indexed as

hypertensionhypertensive crisishypertensive emergencyhypertensive urgencytarget organ damagetherapeutic approach

Identifiers

PMID35683521
PMCPMC9181665
OpenAlexW4281743232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.